Skip to content
healthcare.dev

Paclitaxel protein-bound particles

NDC 69097-398, Paclitaxel protein-bound particles, injection, powder, lyophilized, for suspension, from Cipla USA Inc..

Product NDC
69097-398
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209657
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-398 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PACLITAXEL100 mg/20mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
69097-398-78690970398781 VIAL, SINGLE-DOSE in 1 CARTON (69097-398-78) / 20 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/15eba86c-d9de-42e6-bc95-70ba4c015e72
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=69097-398

Use it

Look up 69097-398 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-398 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-398. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.